Antonella Isgro

Rome, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications

Addressing global regulatory challenges in rare disease drug development.

Addressing global regulatory challenges in rare disease drug development.

Journal: Drug discovery today
Published: June 13, 2025

The roadmap to integrate diversity, equity, and inclusion in hematology clinical trials: an American Society of Hematology initiative.

The roadmap to integrate diversity, equity, and inclusion in hematology clinical trials: an American Society of Hematology initiative.

Journal: Blood advances
Published: June 11, 2024

Outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis in children and adolescents: the retrospective study of the EBMT Paediatric Diseases WP.

Outcomes of allogeneic haematopoietic cell transplantation for myelofibrosis in children and adolescents: the retrospective study of the EBMT Paediatric Diseases WP.

Journal: Bone marrow transplantation
Published: November 14, 2023

Successes and pitfalls in orphan drug development for sickle cell disease.

Successes and pitfalls in orphan drug development for sickle cell disease.

Journal: Blood advances
Published: September 20, 2023

Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties.

Busulfan-fludarabine- or treosulfan-fludarabine-based conditioning before allogeneic HSCT from matched sibling donors in paediatric patients with sickle cell disease: A study on behalf of the EBMT Paediatric Diseases and Inborn Errors Working Parties.

Journal: British journal of haematology
Published: June 02, 2023

Access to medicines for rare diseases: regulatory aspects and public health priorities.

Access to medicines for rare diseases: regulatory aspects and public health priorities.

Journal: Recenti progressi in medicina
Published: July 19, 2022

Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major.

Busulfan-fludarabine- or treosulfan-fludarabine-based myeloablative conditioning for children with thalassemia major.

Journal: Annals of hematology
Published: June 20, 2021

One single bone marrow harvesting from donors under 3 years of age: assessing safety and efficacy of the procedure.

One single bone marrow harvesting from donors under 3 years of age: assessing safety and efficacy of the procedure.

Journal: Bone marrow transplantation
Published: May 21, 2018

Haploidentical HSCT for hemoglobinopathies: improved outcomes with TCRαβ+/CD19+-depleted grafts.

Haploidentical HSCT for hemoglobinopathies: improved outcomes with TCRαβ+/CD19+-depleted grafts.

Journal: Blood advances
Published: August 29, 2017

Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies.

Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: April 18, 2017

Histological features of bone marrow in paediatric patients during the asymptomatic phase of early-stage Black African sickle cell anaemia.

Histological features of bone marrow in paediatric patients during the asymptomatic phase of early-stage Black African sickle cell anaemia.

Journal: Pathology
Published: September 05, 2016

Spirometric Evaluation of Pulmonary Function in Nigerian Children underwent Bone Marrow Transplantation for Sickle Cell Anemia.

Spirometric Evaluation of Pulmonary Function in Nigerian Children underwent Bone Marrow Transplantation for Sickle Cell Anemia.

Journal: Mediterranean journal of hematology and infectious diseases
Published: March 14, 2016
Showing 1-12 of 23

Last Updated: 09/26/2026